Cell-based Assay Market 2028 By Product and Service, Application, End User | The Insight Partners

report image

Cell-based Assay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Consumables, Instruments, Services); Application (Drug Discovery, Basic Research, Other Applications); End User (Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations)

Report Code: TIPRE00006572 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Cell-based assays provide massive data and are essential tools in drug discovery and research applications. Several types of cell-based assays are developed to know and investigate treatment for various diseases. Cell-based assays like cell viability assays, cell proliferation assays, and GPCR assays stimulate drug discovery processes. Many companies have expanded multicellular cell-based assays to understand the complicated pathways within the cellular processes.


The "Global Cell-based Assay Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cell-based assay market with detailed market segmentation by product and service, application, end user, and geography. The report provides key statistics on the market status of the leading cell-based assay market players and offers key trends and opportunities in the market.


  •   Based on product and service, the global cell-based assay market is segmented into consumables, instruments, services.
  •   Based on application, the global cell-based assay market is segmented into drug discovery, basic research, other applications.
  •   Based on end user, the market is bifurcated into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations.


  •   Growing preference for cell-based assays in drug discovery
  •   Increasing funding for cell-based research
  •   Growth in the number of drug discovery activities


  •   High cost of instruments and restrictions on reagent use
  •   Lack of infrastructure for cell-based research in emerging economies

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cell-based assay market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cell-based assay market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Several antiviral drugs or vaccines for COVID-19 have been accepted or are under development, and patients are treated symptomatically. For both vaccines and therapeutics, the antibodies manufactured are tested for their functional efficiency to neutralize the target virus. Cell-based assays are employed to shorten the time and grow the throughput required for these assays. This has significantly increased the demand for cell-based assays to provide initial evidence of the toxicity characteristics of the drug candidates.

Get more information on this report :


The report covers key developments in the cell-based assay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cell-based assay market are anticipated to lucrative growth opportunities in the future with the rising demand for cell-based assay in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cell-based assay market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Thermo Fisher Scientific Inc.
  •   Danaher Corporation
  •   Becton, Dickinson and Company
  •   General Electric Company
  •   Merck KGaA
  •   Lonza Group Ltd.
  •   Perkinelmer, Inc.
  •   Charles River Laboratories, Inc.
  •   Cell Signaling Technology, Inc.
  •   Promega Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Thermo Fisher Scientific Inc.
2. Danaher Corporation
3. Becton, Dickinson and Company
4. General Electric Company
5. Merck KGaA
6. Lonza Group Ltd.
7. Perkinelmer, Inc.
8. Charles River Laboratories, Inc.
9. Cell Signaling Technology, Inc.
10. Promega Corporation
11. Eurofins
12. Cell Biolabs
13. Cell Signaling Technology
14. Bioagilytix Labs Inc.
15. Reaction Biology Corporation
16. AAT Bioquest, Inc.
17. PBL Assay Science
18. Invivogen
19. CA3 Biosciences Inc. (Neuromics)
20. BPS Bioscience
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount